MedPath
FDA Approval

NAPROXEN SODIUM

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
DIRECT RX
DUNS: 079254320
Effective Date
January 21, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Naproxen(550 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

DIRECT RX

DIRECT RX

079254320

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NAPROXEN SODIUM

Product Details

NDC Product Code
61919-165
Application Number
ANDA078432
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 21, 2020
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
POLYVINYL ALCOHOLInactive
Code: 532B59J990Class: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
NaproxenActive
Code: 9TN87S3A3CClass: ACTIBQuantity: 550 mg in 1 1
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQKClass: IACT
MAGNESIUM SULFATE, UNSPECIFIEDInactive
Code: DE08037SABClass: IACT
© Copyright 2025. All Rights Reserved by MedPath